Searchable abstracts of presentations at key conferences in endocrinology

ea0050cmw5.6 | Workshop 5: How do I. . . (2) | SFEBES2017

How do I manage.... myxoedema coma

Brooke Antonia

Myxoedema coma is a rare endocrine emergency with reported high mortality. Exact incidence is hampered by no clear consensus on its definition and the huge variability in its presentation. Most patients are not comatose, and have a form of severe, decompensated hypothyroidism. The common clinical features, including poor mentation, hypothermia, haemodynamic instability and lethargy, correlate poorly to degree of biochemical hypothyroidism. Early detection and identifying commo...

ea0050cmw5.6 | Workshop 5: How do I. . . (2) | SFEBES2017

How do I manage.... myxoedema coma

Brooke Antonia

Myxoedema coma is a rare endocrine emergency with reported high mortality. Exact incidence is hampered by no clear consensus on its definition and the huge variability in its presentation. Most patients are not comatose, and have a form of severe, decompensated hypothyroidism. The common clinical features, including poor mentation, hypothermia, haemodynamic instability and lethargy, correlate poorly to degree of biochemical hypothyroidism. Early detection and identifying commo...

ea0065ns1.2 | NICE – T3 | SFEBES2019

Health care professional & patient consultation – informed decision making

Brooke Antonia

Shared, informed decision making is a key component to high quality care in the NHS. This can occasionally be challenging through lack of time, lack of high-quality trial evidence to support treatment choices and financial limitations to treatment. Informed decision making includes open discussion of the risks and potential adverser consequences of treatment and alternatives. People with endocrine disorders often have symptoms that encompass both their psychological and physic...

ea0059mte10.2 | Service Improvements | SFEBES2018

The Society for Endocrinology peer review scheme

Brooke Antonia

Society for Endocrinology peer review is in its 16th year. In 2018 the format has been updated and single centre reviews are now being carried out. The catchment area of hospitals reviewed has varied from 280 000 to 2.5 million. A review helps to highlight a centre’s strengths and help focus on areas for development. It is a qualitative deep dive into a service which includes benchmarking against other similar services. The review is conducted by a team of clinical endocr...

ea0094esd1.1 | Section | SFEBES2023

Peer review

Brooke Antonia

The need for Peer Review of UK endocrine units was agreed by the Clinical Committee of the Society for Endocrinology in 2001. The service is relevant to the agendas of clinical governance in endocrinology, and ensuring good quality universal care across the UK for patients. Peer Review presents an opportunity to improve patient care, support and facilitate service provision and innovation. Since Covid-19 (2020) there has been significant changes to the way we work and peer rev...

ea0049ep958 | Pituitary - Clinical | ECE2017

Immune checkpoint inhibitors: an emerging cause of hypophysitis

Rizvi Ali , McAdams Brooke

Aim: To describe 2 cases of immune-mediated hypophysitis due to the therapeutic use of Ipilimumab, a cytotoxic T-lymphocyte antigen-4 (CTLA4)-blocking antibody.Case 1: A 62 year-old male with history of metastatic melanoma was started on Ipilimumab. After finishing the 4th at 2 months he complained of weakness, fatigue, and fever, prescribed ciprofloxacin and prednisone 20 mg daily, and felt better. 2 days later he was hospitalized with weakness, BP 86/6...

ea0075d08 | Diabetes | EYES2021

Paraneoplastic hypoglycaemia: An insulin like growth factor-2 producing tumour

Cucknell Catherine , Brooke Antonia

Background: Insulin like growth factor-2 (IGF-2) has structural similarity to insulin1. In excess, IGF-2 can activate glucose metabolism so precipitating hypoglycaemia1.Case Presentation: Six days following her second dose of Doxorubicin and Olaratumab therapy for a pelvic sarcoma, HS presented with two successive days of acute confusion secondary to documented hypoglycaemia (blood sugars 2.0-3.1 mmol/l, 36-55.8 mg/dl). Despite treatment, she had recurre...

ea0091wg6 | Workshop G: Disorders of appetite and weight | SFEEU2023

Post-prandial hypoglycaemia of unknown origin

Koutroukas Vaios , Dhatariya Ketan , Brooke Antonia

Introduction: α 19-year-old female patient with no past medical history presented with multiple collapses following exercise due to hypoglycaemia. From the history it transpired that she had had previous symptoms consistent with hypoglycaemia on multiple occasions, with no relation to fasting or food or a specific diurnal or nocturnal pattern. The two most severe episodes (requiring paramedic treatment) were in the recovery period from anaerobic exercise. Her body mass in...

ea0065p87 | Bone and calcium | SFEBES2019

Investigations in preparation for surgically managed primary hyperparathyroidism

Bennett Robert , Brooke Antonia , Dunn Julie

Background: Recent NICE guidelines1 suggest imaging the parathyroid with ultrasound as first line prior to parathyroidectomy, MIBI as an alternative and surgical exploration if discordant. Investigation should also include a renal ultrasound and DEXA. This audit compares a single surgeon practice in one hospital to the guidelines.Methods and Results: All patients with a parathyroidectomy performed by a single surgeon between July 2016 and July...

ea0042p41 | (1) | Androgens2016

Characterisation of Androgen and Estrogen Receptor Cross-Talk

Alkheilewi Mohammad , Bryan Rosie , Brooke Greg

Worldwide, breast cancer is the most common cancer to develop in women. Steroid receptors play a key role in the progression of the majority of breast cancer subtypes. Estrogen Receptor-α (ERα), for example drives the growth of approximately 70% of tumours and is therefore a useful therapeutic target for this disease. However, the Androgen Receptor (AR) is the highest expressed receptor in normal breast and appears to also play an important role in breast cancer. In ...